Immune cell therapy shows promise for advanced throat cancer
NCT ID NCT05261750
First seen Mar 04, 2026 · Last updated Apr 29, 2026 · Updated 11 times
Summary
This study tests a new treatment using a patient's own immune cells (dendritic cells) combined with donated cell secretions to fight advanced nasopharyngeal cancer. The goal is to see if it is safe and can improve quality of life. The trial involves 15 adults whose cancer did not fully respond to standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PT Prodia StemCell Indonesia
Jakarta, Indonesia
Conditions
Explore the condition pages connected to this study.